PubRank

N L Fox

Author PubWeight™ 16.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dose-response of birth weight to various measures of maternal smoking during pregnancy. J Clin Epidemiol 1988 1.62
2 Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. Eur Heart J 2001 1.58
3 Prenatal exposure to tobacco: II. Effects on cognitive functioning at age three. Int J Epidemiol 1990 1.40
4 Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors. Ann Oncol 2009 1.33
5 A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. Br J Cancer 2010 1.19
6 Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. AJR Am J Roentgenol 1999 1.07
7 Occupational allergy to laboratory animals: an epidemiologic study. J Occup Med 1986 1.05
8 The general concepts of an equivalence trial, applied to ASSENT-2, a large-scale mortality study comparing two fibrinolytic agents in acute myocardial infarction. Eur Heart J 2001 1.01
9 TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation 1997 0.99
10 Inhibition of esterase activity and an undercounting of circulating monocytes in a population of production workers. J Occup Med 1986 0.95
11 Alcohol consumption among pregnant smokers: effects of a smoking cessation intervention program. Am J Public Health 1987 0.83
12 Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. Am Heart J 1999 0.83
13 Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators. Am J Cardiol 1999 0.81
14 Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction. J Clin Pharmacol 2000 0.79
15 Steroid production from 17alpha-hydroxypregnenolone and dehydroepiandrosterone by human granulosa cells in vitro. J Reprod Fertil 1978 0.77
16 Steroidogenesis by cultured granulosa cells aspirated from human follicles using pregnenolone and androgens as precursors. J Endocrinol 1978 0.77
17 Developmental screening using parent report. J Dev Behav Pediatr 1987 0.75
18 Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators. J Thromb Thrombolysis 1999 0.75
19 Determination of a weight-adjusted dose of TNK-tissue plasminogen activator. Am Heart J 2001 0.75
20 How to help meet your patients' spiritual needs. J Pract Nurs 1979 0.75
21 A call to arms. J Pract Nurs 1977 0.75
22 Making geriatric nursing creative. J Pract Nurs 1973 0.75
23 The slap-stick chart. J Pract Nurs 1976 0.75
24 Sound off! Sex in the nursing home? For Lord's sake, why not? RN 1980 0.75
25 A kitten in the care plan? J Pract Nurs 1979 0.75
26 Aftermath of stroke: triumph or tragedy? J Pract Nurs 1975 0.75
27 A good birth, a good life, why not a good death? J Pract Nurs 1974 0.75
28 The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment. J Thromb Thrombolysis 2001 0.75
29 Rx: range-of-motion--for the funnybone. J Pract Nurs 1978 0.75
30 Hallelujah! Common sense at last!. Interview by Ethel Gillette. J Nurs Care 1982 0.75
31 To make meaningful their days. J Pract Nurs 1978 0.75
32 Nursing intervention: holiday happiness...all year 'round. J Pract Nurs 1978 0.75
33 Visible vs. invisible nursing. J Pract Nurs 1978 0.75